Perrigo Company PRGO and Tris Pharma, Inc. today announced the
commercial launch of a major new store brand product. The new product is
equivalent to Delsym® extended–release oral liquid suspension containing
dextromethorphan polistirex and will be marketed under major U.S. retailer and
wholesalers' store brands or own label brands.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in